Climb Bio Inc (CLYM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,851 | -73,897 | -35,119 | -45,244 | -47,480 |
| Depreciation Amortization | -2,177 | -757 | -2,331 | -177 | 370 |
| Accounts payable and accrued liabilities | 1,564 | -963 | -686 | -653 | 318 |
| Other Working Capital | -601 | 1,698 | 3,764 | 210 | -4,172 |
| Other Operating Activity | 6,709 | 58,357 | 13,773 | 8,495 | 14,892 |
| Operating Cash Flow | $-54,356 | $-15,562 | $-20,599 | $-37,369 | $-36,072 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,019 | -111,447 | 68,981 | 34,440 | -114,970 |
| PPE Investments | -186 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -9,645 | 0 | 0 | 0 |
| Investing Cash Flow | $2,833 | $-121,092 | $68,981 | $34,440 | $-114,970 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 65 | 130,729 | 841 | N/A | 83,293 |
| Other Financing Activity | -86 | 0 | 0 | 0 | 93,939 |
| Financing Cash Flow | $-21 | $130,729 | $841 | $N/A | $177,232 |
| Exchange Rate Effect | N/A | 42 | 304 | -408 | 245 |
| Beginning Cash Position | 87,229 | 93,112 | 43,585 | 46,922 | 20,487 |
| End Cash Position | 35,685 | 87,229 | 93,112 | 43,585 | 46,922 |
| Net Cash Flow | $-51,544 | $-5,883 | $49,527 | $-3,337 | $26,435 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,356 | -15,562 | -20,599 | -37,369 | -36,072 |
| Capital Expenditure | -186 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -54,542 | -15,562 | -20,599 | -37,369 | -36,072 |